More about

Hiv Infection

News
January 22, 2020
1 min read
Save

Hooked on ID with Aaron E. Glatt, MD, FACP, FIDSA, FSHEA

Hooked on ID with Aaron E. Glatt, MD, FACP, FIDSA, FSHEA

Some decisions in life are quite difficult and complex; others come more easily and naturally. For me, the latter was the case with my decision to pursue a career in infectious diseases. From early first year pharmacology classes, to learning at the feet of ID giants like Harold Neu, Glenda Garvey, Mark Goldberger and many others in my 3rd and 4th years, going into ID was an easy choice.

News
January 22, 2020
8 min read
Save

Push to end HIV epidemic in US complicated by ‘brain drain’

Fewer medical trainees are entering the field of HIV, leaving a shortage in the workforce that is likely to get worse, experts said. The trend coincides with slowed progress in reducing new infections, and likely complicates a lofty new federal plan to end the U.S. epidemic in 10 years.

News
December 31, 2019
2 min read
Save

Cause-specific opioid mortality research reveals need for combination interventions

Cause-specific opioid mortality research reveals need for combination interventions

Individuals who use illicitly manufactured opioids or pharmaceutical opioids outside the bounds of a medical prescription experience significant yet preventable excess mortality, according to results of a systematic review and meta-analysis published in JAMA Psychiatry.

News
December 10, 2019
1 min read
Save

Top stories in infectious disease: HIV progress stalls, Samoa struggles with measles outbreak

The CDC’s announcement that reductions in HIV infections in the United States have stalled in recent years was the top story in infectious diseases last week.

News
December 03, 2019
2 min read
Save

‘In this case, stability is not good’: HIV incidence at a standstill in US

Progress in reducing new HIV infections in the United States has stalled in recent years, according to newly published CDC data. Experts said accelerated efforts to diagnose, treat and prevent HIV infection are needed to achieve a 90% reduction in new diagnoses by 2030 — one of the goals of a federal HIV plan announced earlier this year.

News
November 16, 2019
2 min read
Save

In ACS, patients with symptomatic HIV less likely to undergo invasive CV procedures

In ACS, patients with symptomatic HIV less likely to undergo invasive CV procedures

PHILADELPHIA — Among patients with ACS, patients with symptomatic HIV appear to be less aggressively treated with diagnostic catheterization, PCI and CABG compared with patients with no or asymptomatic HIV, according to findings presented at the American College of Cardiology Scientific Sessions.

News
November 08, 2019
1 min read
Save

Creatine equations comparable to measured GFR for HIV-positive patients

Creatine equations comparable to measured GFR for HIV-positive patients

WASHINGTON — Ritonavir-boosted protease inhibitors do not significantly impact creatinine-based GFR estimates compared with measured GFR for HIV-positive patients, according to data presented at ASN Kidney Week.

News
October 27, 2019
4 min read
Save

HIV testing increases 15-fold among teens after improvement initiative

HIV testing increases 15-fold among teens after improvement initiative

NEW ORLEANS — A center with typically low HIV testing rates achieved a 15-fold increase in the number of adolescents screened for infection at well visits and a fourfold increase in screening at visits for both preventive and illness concerns.

News
October 22, 2019
3 min read
Save

Tesamorelin ‘very promising’ for reversing liver disease in people with HIV

Tesamorelin ‘very promising’ for reversing liver disease in people with HIV

The injectable hormone tesamorelin reduces liver fat and prevents liver fibrosis in patients living with HIV, suggesting it may provide significant clinical benefits in this population, according to study results published in The Lancet HIV.

News
October 21, 2019
3 min read
Save

‘Like insects in amber’: ART ‘freezes’ latent HIV reservoir

‘Like insects in amber’: ART ‘freezes’ latent HIV reservoir

The latent HIV reservoir is mostly formed soon after the initiation of treatment, suggesting that ART indirectly affects the host environment to favor the establishment of latently infected long-lived cells, researchers reported in Science Translational Medicine.

View more